Skip to main content
logo
Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1400
-0.0050 (-3.45%)
Sep 11, 2026, 3:57 PM HKT

HKG:6833 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
30.3734.8542.0542.3569.46135.08
Depreciation & Amortization
27.0225.524.4216.3211.366.68
Other Amortization
0.080.080.080-0.02
Loss (Gain) From Sale of Assets
--1.14-0.04--
Loss (Gain) From Sale of Investments
-----0.28-0.16
Provision & Write-off of Bad Debts
7.17.1-3.924.256.211.02
Other Operating Activities
174.7939.428.6445.97-5.9722.5
Change in Accounts Receivable
4.084.08-71.98-195.89-133.87364.07
Change in Inventory
92.7892.78-244.31-19.88-26.88181.29
Change in Accounts Payable
21.3621.3655.39444.18-21.2-277.39
Change in Unearned Revenue
-8.88-8.88-12.73-34.9747.68-0.06
Change in Other Net Operating Assets
-8.69-8.69-51.6551.41128.57-127.34
Operating Cash Flow
340.01207.59-232.88353.775.08305.71
Operating Cash Flow Growth
1455.45%--371.09%-75.44%122.66%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-8.38-10.03-35.16-29.55-52.69-23.52
Sale of Property, Plant & Equipment
0.010.01-0.910.3-
Cash Acquisitions
-----68-
Sale (Purchase) of Intangibles
-17.78-17.78-17.92-15.11--
Other Investing Activities
-3.31-0.21-19.871.120.8
Investing Cash Flow
-29.47-27.81-52.87-63.63-119.27-22.73

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-298.92361.1180.02180210
Total Debt Issued
298.92298.92361.1180.02180210
Long-Term Debt Repaid
--466.05-306.34-123.97-341.45-78.66
Lease Payments
-5.94-5.94-4.4-3.97-2.61-0.72
Total Debt Repaid
-466.05-466.05-306.34-123.97-341.45-78.66
Net Debt Issued (Repaid)
-167.13-167.1354.7656.05-161.45131.34
Issuance of Common Stock
----159.4675.37
Common Dividends Paid
-3.67-3.67-7.22-18.11--
Other Financing Activities
-104.35-65.28107.05-227.6637.03-303.83
Financing Cash Flow
-275.15-236.08154.59-189.7335.04-97.11

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-13.43-2.821.568.4312.24-3.59
Net Cash Flow
21.96-59.12-129.6108.783.09182.29

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
331.62197.55-268.04324.1522.39282.19
Free Cash Flow Growth
---1347.74%-92.07%106.09%
Free Cash Flow Margin
17.26%9.48%-9.50%12.76%0.99%13.94%
Free Cash Flow Per Share
0.160.10-0.130.160.010.16
Levered Free Cash Flow
142.3116.17-175.42111.7857.81-85.98
Unlevered Free Cash Flow
150.46125.77-167.57117.9166.44-72.58
Free Cash Flow After Leases
325.69191.62-272.44320.1819.78281.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
33.9433.9416.6414.4318.3322.47
Cash Income Tax Paid
19.0919.0962.237.3739.6641.69
Change in Working Capital
100.65100.65-325.27244.85-5.7140.57